TP53 and sarcoma: Of the TgPTTG/p53+/− females aged to 8 months, 4 out of 10 (40%) had severe dysplasia of the cervix resulting in carcinomas in situ (Figure 12) along with 1 out of 10 (10%) developing a sarcoma.